Cellestia appointed David Epstein as Chairman of the Strategic Advisory Board.
Cellestia appointed David Epstein as Chairman of the Strategic Advisory Board.
First patient dosed in first-in-human Phase l – lla clinical study with CB-103
New Appointment to the Clinical Advisory Board